300 related articles for article (PubMed ID: 6311924)
1. Human hepatoma cell line plasminogen activator.
Levin EG; Fair DS; Loskutoff DJ
J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2.
Sprengers ED; Princen HM; Kooistra T; van Hinsbergh VW
J Lab Clin Med; 1985 Jun; 105(6):751-8. PubMed ID: 2987382
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells.
Moscatelli D
J Cell Biochem; 1986; 30(1):19-29. PubMed ID: 3082899
[TBL] [Abstract][Full Text] [Related]
4. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.
Levin EG; Loskutoff DJ
J Cell Biol; 1982 Sep; 94(3):631-6. PubMed ID: 6813340
[TBL] [Abstract][Full Text] [Related]
5. Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia.
Bergonzelli GE; Kruithof EK
J Cell Physiol; 1991 Aug; 148(2):306-13. PubMed ID: 1652590
[TBL] [Abstract][Full Text] [Related]
6. Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells.
Laug WE
Thromb Haemost; 1985 Apr; 53(2):165-9. PubMed ID: 3927503
[TBL] [Abstract][Full Text] [Related]
7. Characterization of plasminogen activator from two human renal carcinoma cell lines.
Nelson NF; Cieplak W; Dacus SC; Prager MD
J Cell Physiol; 1986 Mar; 126(3):435-43. PubMed ID: 2419348
[TBL] [Abstract][Full Text] [Related]
8. Characterization of plasminogen activator produced by an established cell line from human ovary.
Matsuo C; Fukao H; Matsuo O
J Cell Physiol; 1988 Feb; 134(2):253-60. PubMed ID: 3126195
[TBL] [Abstract][Full Text] [Related]
9. The differential glycosylation of human pro-urokinase from various recombinant mammalian cell lines does not affect activity and binding to PAI-1.
Sarubbi E; Nolli ML; Robbiati F; Soffientini A; Parenti F; Cassani G
Thromb Haemost; 1989 Nov; 62(3):927-33. PubMed ID: 2512681
[TBL] [Abstract][Full Text] [Related]
10. Relationship between circulating plasminogen activators and tumor development in mice.
Colombi M; Rebessi L; Boiocchi M; Barlati S
Cancer Res; 1986 Nov; 46(11):5748-53. PubMed ID: 3093069
[TBL] [Abstract][Full Text] [Related]
11. Regulation of plasminogen activator activity in human fibroblastic cells by fibrosarcoma cell-derived factors.
Saksela O; Laiho M; Keski-Oja J
Cancer Res; 1985 May; 45(5):2314-9. PubMed ID: 3921241
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human tumor cell-associated fibrinolysis by vascular bovine smooth muscle cells.
Laug WE
J Natl Cancer Inst; 1985 Aug; 75(2):345-52. PubMed ID: 3860687
[TBL] [Abstract][Full Text] [Related]
13. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activators and their inhibitors in the neuromuscular system: I. Developmental regulation of plasminogen activator isoforms during in vitro myogenesis in two cell lines.
Festoff BW; Rao JS; Maben C; Hantaï D
J Cell Physiol; 1990 Aug; 144(2):262-71. PubMed ID: 2199466
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
Waghray A; Webber MM
Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells.
Corti A; Nolli ML; Soffientini A; Cassani G
Thromb Haemost; 1986 Oct; 56(2):219-24. PubMed ID: 3101222
[TBL] [Abstract][Full Text] [Related]
17. Schwann cell plasminogen activator is regulated by neurons.
Clark MB; Zeheb R; White TK; Bunge RP
Glia; 1991; 4(5):514-28. PubMed ID: 1834568
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids inhibit plasminogen activator production by endothelial cells.
Laug WE
Thromb Haemost; 1983 Dec; 50(4):888-92. PubMed ID: 6420927
[TBL] [Abstract][Full Text] [Related]
19. Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors.
Colucci M; Gesualdo L; Montemurro P; Cavallo LG; Conese M; Mascolo E; Ranieri E; Di Paolo S; Schena FP; Semeraro N
Thromb Haemost; 1995 Dec; 74(6):1516-20. PubMed ID: 8772230
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.
Hayashi K; Nakashima Y; Sueishi K; Tanaka K
Jpn J Ophthalmol; 1989; 33(1):66-75. PubMed ID: 2499726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
